The International Trade Commission seeks comments by May 2 on a Section 337 complaint alleging that imports of balloon dilation devices infringe patents held by Entellus Medical, Stryker Corporation, and Stryker Sales, it said in a notice set for April 24 publication. According to the complaint, the complainants are seeking a limited exclusion order and cease and desist orders against German company Fiagon and U.S. parent company Hemostasis to bar from entry "certain balloon dilation devices, systems, and components thereof," that violate the complainant's patents. The complainants described the products as medical "components for tracking, guiding, illuminating, and/or navigating" for "illuminating nasal and sinus cavities for treatment of sinusitis."
The International Trade Commission is seeking public input on remedies for its Section 337 investigation on HydraFacial's imported Syndeo hydrodermabrasion system (ITC Inv. No. 337-TA-1417), it said in a notice to be published April 24. The ITC initiated the investigation in September 2024 based on allegations that Germany-based MIRAmedtech and its Polish and U.S. affiliates and several other companies were importing the Cleopatra and MIRApeel systems (see 2409170039). The ITC partially terminated the investigation with respect to three of the respondents and the administrative law judge subsequently found the remaining respondents, including MIRAmedtech, in default. The ITC determined not to review the ALJ's determination and is requesting written submissions by “close of business” on May 2.
The Commerce Department published notices in the Federal Register April 23 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department issued its final affirmative determinations in the antidumping and countervailing duty investigations on imports of certain high chrome cast iron grinding media from India, it said in a fact sheet issued April 22. Commerce set AD rates at 9.58% and CVD rates at 3.16% for Indian exporters, the agency said. These rates will take effect upon publication in the Federal Register of these final determinations, which should occur in the coming days.
On April 22, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notices April 23:
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website April 22, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
CBP issued the following releases on commercial trade and related matters:
More and more companies are requesting bonds that are worth millions of dollars and even "up to the billions at this point" as importers seek to ensure they have enough bonding to cover anticipated higher duties, Patrice Lafayette of Roanoke Insurance Group said during an April 23 webinar on tariffs hosted by Flexport.
Comments from President Donald Trump and from a private talk by Treasury Secretary Scott Bessent on April 22 gave importers hope that the triple-digit tariffs on Chinese imports will drop soon. But Bessent, speaking to Bloomberg after a speech on April 23 at the Institute of International Finance, said there is no plan for the U.S. to drop its tariffs unilaterally, and that there is no timeline for engagement with China.